Loading clinical trials...
Loading clinical trials...
Heart Rate Variability Biofeedback in the Treatment of Ulcerative Colitis
This is a prospective interventional study exploring the modifiability of physiological metrics, namely Heart Rate Variability (HRV), using a 5-week standardized HRV biofeedback intervention in subjects with symptomatic ulcerative colitis. Participants will be followed for 17 weeks. The goal is the understand if modifying these markers can impact ulcerative colitis related symptoms.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Start Date
June 1, 2026
Primary Completion Date
April 30, 2027
Completion Date
April 30, 2027
Last Updated
March 13, 2026
23
ESTIMATED participants
HRV biofeedback
BEHAVIORAL
Lead Sponsor
Icahn School of Medicine at Mount Sinai
NCT07271069
NCT06975722
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07185009